Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8342
|
pubmed:dateCreated |
1983-8-17
|
pubmed:abstractText |
In a double-blind, dose-comparative trial, 32 patients with duodenal ulcer were assigned to receive either 20 mg/day or 60 mg/day omeprazole for 4 weeks. The 2-week healing frequency of 100% in the 60 mg/day group was significantly higher than that in the 20 mg/day group (63%). After 4 weeks all ulcers but one in the 20 mg/day group were healed (93% healing frequency). In both groups transient and mostly slight rises in serum alanine aminotransferase levels were observed (total 10 patients). One patient in the 20 mg/day group was withdrawn because of a pronounced rise in serum alanine aminotransferase on day 8. The reason for these liver reactions is not clear, but exclusion of a causal relation with omeprazole treatment must precede further clinical evaluation of this drug.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0140-6736
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
16
|
pubmed:volume |
2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
124-5
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:6134979-Alanine Transaminase,
pubmed-meshheading:6134979-Benzimidazoles,
pubmed-meshheading:6134979-Clinical Trials as Topic,
pubmed-meshheading:6134979-Double-Blind Method,
pubmed-meshheading:6134979-Duodenal Ulcer,
pubmed-meshheading:6134979-Female,
pubmed-meshheading:6134979-Gastric Acid,
pubmed-meshheading:6134979-Humans,
pubmed-meshheading:6134979-Male,
pubmed-meshheading:6134979-Omeprazole,
pubmed-meshheading:6134979-Random Allocation,
pubmed-meshheading:6134979-Time Factors
|
pubmed:year |
1983
|
pubmed:articleTitle |
Rapid healing of duodenal ulcers with omeprazole: double-blind dose-comparative trial.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|